The X-X-/E+E+ genotype of the XbaI/EcoRI polymorphisms of the apolipoprotein B gene as a marker of coronary artery disease in a Brazilian sample

Brazilian Journal of Medical and Biological Research

Volumn 36, Issue 3, 2003, Pages 369-375

  Scartezini, Marileia ^a   Zago, M A ^b   Chautard Freire Maia, E A ^a   Pazin Filho, A ^b   Marin Neto, J A ^b   Hotta, J K S ^b   Nascimento, A J ^a   Dos Santos, J E ^b  

^a FEDERAL UNIVERSITY OF PARANÁ   (Brazil)

^b UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Apo B XbaI EcoRI polymorphisms; CAD risk; Coronary artery disease

Indexed keywords

APOLIPOPROTEIN B; CHOLESTEROL; DNA; RESTRICTION ENDONUCLEASE; TRIACYLGLYCEROL;

ADULT; ANGIOCARDIOGRAPHY; BRAZIL; CIGARETTE SMOKING; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DISEASE COURSE; FEMALE; GENDER; GENE FREQUENCY; GENE LINKAGE DISEQUILIBRIUM; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC VARIABILITY; GENOTYPE; HEART MUSCLE ISCHEMIA; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; MARKER GENE; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; POPULATION RESEARCH; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; REVIEW; RISK FACTOR;

NICOTIANA TABACUM;

EID: 0037361471     PISSN: 0100879X     EISSN: 1414431X     Source Type: Journal    
DOI: 10.1590/S0100-879X2003000300012     Document Type: Review

References (28)

1. Barni N, Talmud PJ, Carlsson P et al. (1986). The isolation of genomic recombinants for the human apolipoprotein B gene and the mapping of three common DNA polymorphisms of the gene - a useful marker for human chromosome 2. Human Genetics, 73: 313-319.
2. Priestley L, Knott T, Wallis S, Powell L, Pease R, Brunt H & Scott J (1985). RFLP for the human apolipoprotein B gene: I, BamHI; II, EcoRI; III, EcoRV; IV, MspI; V, XbaI. Nucleic Acids Research, 13: 6789-6793.
3. Law A, Powell LM, Brunt H et al. (1986). Common DNA polymorphism within coding sequence of apolipoprotein B gene associated with altered lipid levels. Lancet, 1: 1301-1303.
4. Blackhart BD, Ludwig EM, Pierotti VR et al. (1986). Structure of the human apolipoprotein B gene. Journal of Biological Chemistry, 261: 15364-15367.
5. Shoulders CC, Myant NB, Sidoli A, Rodriguez JC, Cortese C, Baralle FE & Cortese R (1985). Molecular cloning of human LDL-apolipoprotein B cDNA. Evidence for more than one gene per haploid genome. Atherosclerosis, 58: 277-292.
6. Hegele RA, Huang L, Herbert PN, Blum CB, Buring JE, Hennekens CH & Breslow JL (1986). Apolipoprotein B-gene DNA polymorphisms associated with myocardial infarction. New England Journal of Medicine, 315: 1509-1515.
7. Monsalve MV, Young R, Jobsis J, Wiseman SA, Dhamu S, Powell JT, Greenhalgh RM & Humphries SE (1988). DNA polymorphisms of the gene for apolipoprotein B in patients with peripheral arterial disease. Atherosclerosis, 70: 123-129.
8. Myant NB, Gallagher J, Barbir M, Thompson GR, Wile D & Humphries SE (1989). Restriction fragment length polymorphism in the apo-B-gene in relation to coronary-artery disease. Atherosclerosis, 77: 193-201.
9. Tybjaerg-Hansen A, Nordestgaard BG, Gerdes LU & Humphries SE (1991). Variation of apolipoprotein B gene is associated with myocardial infarction and lipoprotein levels in Danes. Atherosclerosis, 89: 69-81.
10. Bohn M, Bakken A, Erikssen J & Berg K (1993). XbaI polymorphism in DNA at the apolipoprotein B locus is associated with myocardial infarction (MI). Clinical Genetics, 44: 241-248.
11. Friedewald WT, Levy RI & Fredrickson DS (1972). Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clinical Chemistry, 18: 499-502.
12. Saiki RK, Gelfand DH, Stoffel S, Scharf SJ, Higuchi R, Horn GT, Mullis KB & Erlich HA (1988). Primer-directed enzymatic amplification of DNA with a thermostable DNA polymerase. Science, 239: 487-491.
13. Renges HH, Peacock R, Dunning AM, Talmud P & Humphries SE (1992). Genetic relationship between the 3′VNTR and diallelic apolipoprotein B gene polymorphisms: haplotype analysis in individuals of European and South Asian origin. Annals of Human Genetics, 56: 11-33.
14. Excoffier L, Schneider S, Kueffer JM & Roessli D (1997). Arlequin: version 1.1. Geneva. Download in 1998. http://anthropologie.unige.ch/arlequin.
15. Hosmer Jr DW & Lemeshow S (1989). Applied Logistic Regression. John Wiley & Sons, Inc., New York, NY, USA, 44.
16. Machado MO, Hirata MH, Bertolami MC & Hirata RDC (2001). Apo B gene haplotype is associated with lipid profile of higher risk for coronary heart disease in Caucasian Brazilian men. Journal of Clinical Laboratory Analysis, 15: 19-24.
17. Bohn M & Berg K (1994). The XbaI polymorphism at the apolipoprotein B locus and risk of atherosclerotic disease. Clinical Genetics, 46: 77-79.
18. Deeb S, Failor A, Brown BG, Brunzell JD, Albers JJ & Motulsky AG (1986). Molecular genetics of apolipoprotein and coronary heart disease. Cold Spring Harbor Symposia on Quantitative Biology, 56: 403-409.
19. Ferns GAA, Robinson D & Galton DJ (1988). DNA haplotypes of the human apolipoprotein B gene in coronary atherosclerosis. Human Genetics, 81: 76-80.
20. Wiklund O, Darnfors C, Bjursell G, Nilsson J, Linden T, Olofsson SO, Wilhelmsen L & Bondjers G (1989). XbaI restriction fragment length polymorphism of apolipoprotein B in Swedish myocardial infarction patients. European Journal of Clinical Investigation, 19: 255-258.
21. Genest JJ, Ordovas JM, McNamara JR et al. (1990). DNA polymerphisms of the apolipoprotein B gene in patients with premature coronary artery disease. Atherosclerosis, 82: 7-17.
22. Paulweber B, Frield W, Krempler F, Humphries SE & Sandhofer F (1990). Association of DNA polymorphism at the apolipoprotein B gene locus with coronary heart disease and serum very low density lipoprotein levels. Arteriosclerosis, 10: 17-24,
23. Peacock R, Dunning A, Hamsten A, Tornvall P, Humphries SE & Talmud P (1992). Apolipoprotein B gene polymorphism, lipoproteins and coronary atherosclerosis: a study of young myocardial infarction survivors and healthy population-based individuals. Atherosclerosis, 92: 151-164.
24. Nieminen MS, Mattila KJ, Aalto-Setälä K, Kuusi T, Kontula K, Kauppinen-Mäkelin R, Ehnholm C, Jauhiainen M, Valle M & Taskinen M-R (1992). Lipoproteins and their genetic variation in subjects with and without angiographically verified coronary artery disease. Arteriosclerosis and Thrombosis, 12: 58-69.
25. Salazar LA, Hirata MH, Giannini SD, Forti N, Diament J, Lima TM & Hirata RD (2000). Seven DNA polymorphisms at the candidate genes of atherosclerosis in Brazilian women with angiographically documented coronary artery disease. Clinica Chimica Acta, 300: 139-149.
26. Turner PR, Talmud PJ, Visvikis S, Ehnholm C & Tiret L (1995). DNA polymorphisms of the apoprotein B gene are associated with altered plasma lipoprotein concentrations but not with perceived risk of cardiovascular disease: European Atherosclerosis Research Study. Atherosclerosis, 116: 221-234.
27. Pan J, Chiang A, Tai JJ, Wang S & Chang M (1995). Restriction fragment length polymorphisms of apolipoprotein B gene in Chinese population with coronary heart disease. Clinical Chemistry, 41: 424-429.
28. Guzman EC, Hirata MH, Quintão EC & Hirata RD (2000). Association of the apolipoprotein B gene polymorphisms with cholesterol levels and response to fluvastatin in Brazilian individuals with high risk for coronary heart disease. Clinical Chemistry and Laboratory Medicine, 38: 731-736.